Allurion Technologies, Inc.
ALUR- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001964979
No open-market purchases or sales by Allurion Technologies, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesALURW
Q2 2025 vs. Q1 2025
How the institutions holding Allurion Technologies, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 24 | 1 | 21 | −2 |
| Shares | 1.39M | 10.9K | 2.82M | +1.43M (+103.6%) |
| Value | $4.44M | $318 | $6.84M | +$2.40M (+54.1%) |
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Allurion Technologies, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 14,835 | $36.0K | 0.00% |
| LRI Investments, LLC | 8,185 | $19.9K | 0.00% |
| Citigroup Inc | 1,679 | $4.08K | 0.00% |
| Raymond James Financial Inc | 63 | $153 | 0.00% |
Sold out (6)
Institutions that held Allurion Technologies, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| HRT Financial LP | 42,724 | $137.0K |
| Sabby Management, LLC | 27,890 | $89.5K |
| Morgan Stanley | 53 | $170 |
| Parallel Advisors, LLC | 10 | $32 |
| Barclays PLC | 9 | $29 |
| FMR LLC | 8 | $26 |
Not filed for Q2 2025 yet (1)
Institutions that held Allurion Technologies, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Caas Capital Management LP | 10,950 | $318 |